ALEXANDRIA, Va., June 2 -- United States Patent no. 12,643,993, issued on June 2, was assigned to Medcura Inc. (Riverdale, Md.).
"Hydrophobically modified chitosan compositions" was invented by Matthew Dowling (Riverdale, Md.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein is a polymer composition comprising an effective amount of a hydrophobically-modified polymer having functional groups along the backbone occupied by a fatty acid anhydride moiety. The polymer composition has a potent hemostatic action by gelling blood upon contact, and is suitable for treating internal and external bleeds. As disclosed herein, the modified polymer can be generated without the use of toxic reagents that wou...